Hiraiwa, Hiroaki http://orcid.org/0000-0002-1606-7037
Okumura, Takahiro http://orcid.org/0000-0001-5076-2052
Kondo, Toru
Kato, Toshiaki
Kazama, Shingo
Kimura, Yuki
Ishihara, Toshikazu
Iwata, Etsuo
Shimojo, Masafumi
Kondo, Sayano
Aoki, Soichiro
Kanzaki, Yasunori
Tanimura, Daisuke
Sano, Hiroaki
Awaji, Yoshifumi
Yamada, Sumio
Murohara, Toyoaki
Article History
Received: 2 September 2020
Accepted: 25 December 2020
First Online: 22 January 2021
Compliance with ethical standards
:
: T.O. received research grants from Ono Pharmaceutical Co., Ltd., Bayer Pharmaceutical Co., Ltd., Daiichi-Sankyo Pharma Inc., and Amgen Astellas BioPharma K.K. outside the submitted work. T.O. received honorariums from Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Medtronic Japan Co., Ltd. T.M. received lecture fees from Bayer Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Pfizer Japan Inc., Sanofi-Aventis K. K., and Takeda Pharmaceutical Co., Ltd. T.M. received an unrestricted research grant from the Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-Aventis K. K., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. The remaining authors declare that there are no conflicts of interest.